TSMHT
JAZZ icon

Thurston Springer Miller Herd & Titak’s Jazz Pharmaceuticals JAZZ Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.2K Buy
+254
New +$55.6K 0.02% 434
2025
Q4 		– Sell
-1
Closed -$131 – 1365
2025
Q3 		$131 Sell
1
-41
-98% -$4.92K ﹤0.01% 535
2025
Q2 		$4.46K Hold
42
– – ﹤0.01% 1306
2025
Q1 		$5.21K Hold
42
– – ﹤0.01% 1268
2024
Q4 		$5.17K Sell
42
-23
-35% -$2.71K ﹤0.01% 1010
2024
Q3 		$7.24K Buy
65
+1
+2% +$110 ﹤0.01% 1122
2024
Q2 		$6.83K Buy
+64
New +$7.04K ﹤0.01% 1120

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's JAZZ Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 254 shares worth $61.2K. The stake represents 0.02% of the portfolio and ranks #434 among its holdings. This is a return to the name: Thurston Springer Miller Herd & Titak previously reported a position in JAZZ as recently as Q3 2025.

Thurston Springer Miller Herd & Titak first reported a position in JAZZ in Q2 2024 and has held it in 7 quarters since. 164 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 254 shares of Jazz Pharmaceuticals worth $61.2K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Thurston Springer Miller Herd & Titak position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.02% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #434 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • 164 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.